Liver MRI: From basic protocol to advanced techniques

Thian, 2013, Liver-specific agents for contrast-enhanced MRI: role in oncological imaging, Cancer Imag., 13, 567, 10.1102/1470-7330.2013.0050 Matos, 2015, Focal liver lesions: practical magnetic resonance imaging approach, World J. Hepatol., 7, 1987, 10.4254/wjh.v7.i16.1987 Van Beers, 2015, New imaging techniques for liver diseases, J. Hepatol., 62, 690, 10.1016/j.jhep.2014.10.014 Guglielmo, 2014, Hepatic MR imaging techniques, optimization, and artifacts, Magn. Reson. Imag. Clin. N. Am., 22, 263, 10.1016/j.mric.2014.04.004 O’Neill, 2015, The ins and outs of liver imaging, Clin. Liver Dis., 19, 99, 10.1016/j.cld.2014.09.006 Taupitz, 2009, The liver, 1 Wile, 2010, Magnetic resonance imaging of the liver: sequence optimization and artifacts, Magn. Reson. Imag. Clin. N. Am., 18, 525, 10.1016/j.mric.2010.07.010 Chang, 2008, 3.0-T MR imaging of the abdomen: comparison with 1.5T, Radiographics, 28, 1983, 10.1148/rg.287075154 Ramalho, 2007, Liver MR imaging: 1.5T versus 3T, Magn. Reson. Imag. Clin. N. Am., 15, 321, 10.1016/j.mric.2007.06.003 LeBedis, 2012, Use of magnetic resonance imaging contrast agents in the liver and biliary tract, Magn. Reson. Imag. Clin. N. Am., 20, 716, 10.1016/j.mric.2012.07.006 Chilla, 2015, Diffusion weighted magnetic resonance imaging and its recent trend-a survey, Quant. Imag. Med. Surg., 5, 407 Lewis, 2014, Diffusion-weighted imaging of the liver: techniques and applications, Magn. Reson. Imag. Clin. N. Am., 22, 373, 10.1016/j.mric.2014.04.009 Boyle, 2006, An interactive taxonomy of MR imaging sequences, Radiographics, 26, e24, 10.1148/rg.e24 Albiin, 2012, MRI of focal liver lesions, Curr. Med. Imag. Rev., 8, 107, 10.2174/157340512800672216 M.M. Jafar, A. Parsai, M.E. Miquel, Diffusion-weighted magnetic resonance imaging in cancer: Reported apparent diffusion coefficients, in-vitro and in-vivo reproducibility, World J Radiol. 8 (2016) 21–49. 10.4329/wjr.v8.i1.21. Bashir, 2014, Magnetic resonance contrast agents for liver imaging, Magn. Reson. Imaging Clin. N. Am., 22, 283, 10.1016/j.mric.2014.04.002 Huh, 2015, Troubleshooting arterial-phase MR images of gadoxetate disodium-enhanced liver, Korean J. Radiol., 16, 1207, 10.3348/kjr.2015.16.6.1207 Neri, 2016, ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents, Eur. Radiol., 26, 921, 10.1007/s00330-015-3900-3 Jhaveri, 2015, Consensus statements from a multidisciplinary expert panel on the utilization and application of a liver-specific MRI Contrast agent (gadoxetic acid), Am. J. Roentgenol., 204, 498, 10.2214/AJR.13.12399 Burke, 2013, The role of hepatocyte-specific contrast agents in hepatobiliary magnetic resonance imaging, Semin. Ultrasound CT MRI, 34, 44, 10.1053/j.sult.2012.11.004 R. Girometti, 3.0 Tesla magnetic resonance imaging: A new standard in liver imaging?, World J. Hepatol. 7 (2015) 1894. doi: 10.4254/wjh.v7. i15.1894. Joo, 2016, Monitoring vascular disrupting therapy in a rabbit liver model: relationship between tumor perfusion parameters at IVIM diffusion-weighted MR imaging and those at dynamic contrast-enhanced MR Imaging, Radiology, 278, 104, 10.1148/radiol.2015141974 McKeage, 2010, Disrupting established tumor blood vessels: an emerging therapeutic strategy for cancer, Cancer, 116, 1859, 10.1002/cncr.24975 Salmon, 2007, Monitoring the treatment efficacy of the vascular disrupting agent CA4P, Eur. J. Cancer, 43, 1622, 10.1016/j.ejca.2007.03.018 Miller, 2005, Imaging angiogenesis: applications and potential for drug development, J. Natl. Cancer Inst., 97, 172, 10.1093/jnci/dji023 Goh, 2007, Quantitative tumor perfusion assessment with multide- tector CT: are measurements from two commercial software packages interchangeable?, Radiology, 242, 777, 10.1148/radiol.2423060279 Chen, 2014, DCE-MRI in hepatocellular carcinoma- clinical and therapeutic image biomarker, World J. Gastroenterol., 20, 3125, 10.3748/wjg.v20.i12.3125 Brix, 2010, Tracer kinetic modelling of tumour angiogenesis based on dynamic contrast- enhanced CT and MRI measurements, Eur. J. Nucl. Med. Mol. Imag., 37, S30, 10.1007/s00259-010-1448-7 Sourbron, 2010, Technical aspects of MR perfusion, Eur. J. Radiol., 76, 304, 10.1016/j.ejrad.2010.02.017 Thng, 2010, Perfusion magnetic resonance imaging of the liver, World J. Gastroenterol., 16, 1598, 10.3748/wjg.v16.i13.1598 Tofts, 1991, The MRI measurement of NMR and physiological parameters in tissue to study disease process, Prog. Clin. Biol. Res., 363, 313 Brix, 1991, Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging, J. Comput. Assist. Tomogr., 15, 621, 10.1097/00004728-199107000-00018 Larsson, 1990, Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors, Magn. Reson. Med., 16, 117, 10.1002/mrm.1910160111 Materne, 2002, Assessment of hepatic perfusion parameters with dynamic MRI, Magn. Reson. Med., 47, 135, 10.1002/mrm.10045 Wang, 1987, Optimizing the precision in T1 relaxation estimation using limited flip angles, Magn. Reson. Med., 5, 399, 10.1002/mrm.1910050502 Reeder, 2011, Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy, J. Magn. Reson. Imag., 34, 10.1002/jmri.22580 Reeder, 2012, Proton density fat-fraction: a standardized MR-based biomarker of tissue fat concentration, J. Magn. Reson. Imag., 36, 1011, 10.1002/jmri.23741 Liu, 2007, Fat quantification with IDEAL gradient echo imaging: correction of bias from T1 and noise, Magn. Reson. Med., 58, 354, 10.1002/mrm.21301 Wang, 2015, Sensitivity of chemical shift-encoded fat quantification to calibration of fat MR spectrum, Magn. Reson. Med., 75, 845, 10.1002/mrm.25681 Martí-Bonmatí, 2011, Overload hepatitides: quanti-qualitative analysis, Abdom. Imag., 37, 180, 10.1007/s00261-011-9762-5 França, 2017, Accurate simultaneous quantification of liver steatosis and iron overload in diffuse liver diseases with MRI, Abdom. Radiol., 10.1007/s00261-017-1048-0 Yokoo, 2014, Fat and iron quantification in the liver: past, present, and future, Top. Magn. Reson. Imag., 23, 73, 10.1097/RMR.0000000000000016 Tang, 2013, Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis, Radiology, 267, 422, 10.1148/radiol.12120896 Idilman, 2013, Hepatic steatosis quantification by proton density fat fraction with MR imaging versus liver biopsy, Radiology, 267, 767, 10.1148/radiol.13121360 Tyagi, 2015, Intra- and inter-examination repeatability of magnetic resonance spectroscopy, magnitude-based MRI, and complex-based MRI for estimation of hepatic proton density fat fraction in overweight and obese children and adults, Abdom. Imag., 40, 3070, 10.1007/s00261-015-0542-5 Kang, 2011, Reproducibility of MRI-determined proton density fat fraction across two different MR scanner platforms, J. Magn. Reson. Imag., 34, 928, 10.1002/jmri.22701 Gandon, 2004, Non-invasive assessment of hepatic iron stores by MRI, Lancet, 363, 357, 10.1016/S0140-6736(04)15436-6 Sirlin, 2010, Magnetic resonance imaging quantification of liver iron, Magn. Reson. Imag. Clin. N. Am., 18, 359, 10.1016/j.mric.2010.08.014 Wood, 2014, Use of magnetic resonance imaging to monitor iron overload, Hematol. Oncol. Clin. N. Am., 28, 747, 10.1016/j.hoc.2014.04.002 St Pierre, 2005, Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance, Blood, 105, 855, 10.1182/blood-2004-01-0177 Wood, 2005, MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients, Blood, 106, 1460, 10.1182/blood-2004-10-3982 Garbowski, 2014, Biopsy-based calibration of T2* magnetic resonance for estimation of liver iron concentration and comparison with R2 Ferriscan, J. Cardiovasc. Magn. Reson., 16, 1, 10.1186/1532-429X-16-40 Godfrey, 2013, Magnetic resonance elastography in the diagnosis of hepatic fibrosis, Semin. Ultrasound CT MR, 34, 81, 10.1053/j.sult.2012.11.007 Glaser, 2012, Review of MR elastography applications and recent developments, J. Magn. Reson. Imag., 36, 757, 10.1002/jmri.23597 Venkatesh, 2013, Magnetic resonance elastography of liver: technique, analysis, and clinical applications, J. Magn. Reson. Imag., 37, 544, 10.1002/jmri.23731 Mariappan, 2016, Application of modified spin-echo-based sequences for hepatic MR elastography: evaluation, comparison with the conventional gradient-echo sequence, and preliminary clinical experience, Radiology, 282, 390, 10.1148/radiol.2016160153 Banerjee, 2014, Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease, J. Hepatol., 60, 69, 10.1016/j.jhep.2013.09.002 Pavlides, 2016, Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease, J. Hepatol., 64, 308, 10.1016/j.jhep.2015.10.009 Taouli, 2010, Diffusion-weighted MR imaging of the liver, Radiology, 254, 47, 10.1148/radiol.09090021 França, 2016, Evaluation of fibrosis and inflammation in diffuse liver diseases using intravoxel incoherent motion diffusion-weighted MR imaging, Abdom. Radiol. H.S. Leitão, S. Doblas, G. d’Assignies, P. Garteiser, J.L. Daire, V. Paradis, C.F. Geraldes, V. Vilgrain, B.E. Van Beers, Fat deposition decreases diffusion parameters at MRI: a study in phantoms and patients with liver steatosis, Eur. Radiol. 23 (2012) 461-7. doi:10.1007/s00330-012-2626-8.